Litigation Details for Novo Nordisk A/S v. Sun Pharmaceutical Industries Ltd. (D. Del. 2022)
✉ Email this page to a colleague
Novo Nordisk A/S v. Sun Pharmaceutical Industries Ltd. (D. Del. 2022)
| Docket | ⤷ Try a Trial | Date Filed | 2022-03-03 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 10,335,462; 9,132,239 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Novo Nordisk A/S v. Sun Pharmaceutical Industries Ltd.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Biologic Drugs cited in Novo Nordisk A/S v. Sun Pharmaceutical Industries Ltd.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Novo Nordisk A/S v. Sun Pharmaceutical Industries Ltd. (D. Del. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-03-03 | 1 | Complaint | United States Patent Nos. 9,132,239 (the “’239 patent”) and 10,335,462 (the “’462 patent”), which cover… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 10,335,462 28. Novo Nordisk re-alleges… 1. This is an action for patent infringement under the patent laws of the United States, Title… THE PATENTS-IN-SUIT 14. On September 15, 2015, the United States Patent and Trademark…interest in the ’239 patent. 15. On July 2, 2019, the United States Patent and Trademark Office | External link to document |
| 2022-03-03 | 4 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,132,239 B2 ;10,335,462 B2. (apk) (… 4 March 2022 1:22-cv-00296 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
